Deep Brain Stimulation (DBS)

Deep brain stimulation is a treatment in which thin electrodes are placed with great precision into specific deep structures of the brain and connected, through wires running under the skin, to a small battery-powered stimulator implanted near the collarbone, much like a heart pacemaker. The stimulator delivers continuous, carefully measured electrical pulses that quieten the disordered signals causing tremor, rigidity, slowness or abnormal posturing. It does not cure the underlying disease, but by helping the brain's movement circuits work more smoothly it can dramatically reduce symptoms and the need for high doses of medication. A key advantage is that the system is fully adjustable: the strength and pattern of stimulation can be fine-tuned to each patient as the disease changes, and the whole system can be turned off or removed if ever needed. The result is a flexible, reversible treatment shaped around the individual.

Deep brain stimulation is considered when a movement disorder is no longer well controlled by medication, or when medication helps but causes troubling side effects such as involuntary movements or unpredictable swings between good and bad periods. It is most established for advanced Parkinson's disease, essential tremor that does not settle with drugs, and several forms of dystonia, where it can ease tremor, stiffness and abnormal muscle contractions. It is also used in selected cases of drug-resistant epilepsy and certain severe obsessive-compulsive disorder, and research continues into further conditions. It is not the right choice for everyone: candidates are chosen carefully after detailed assessment, because the treatment works best in people whose symptoms still respond at least partly to medication and who do not have advanced memory problems. The aim throughout is a clear, lasting gain in daily function.

Planning begins with high-resolution brain imaging that is fed into a computer to calculate the exact target points, often within a millimetre. Electrode placement is usually carried out with the patient awake but comfortable under local anaesthesia, because the brain has no pain nerves and being awake lets the team test the stimulation and confirm it eases symptoms without unwanted effects before fixing the electrodes. A precise guiding frame or frameless navigation holds the trajectory, and in some centres the placement is done fully asleep using detailed imaging to verify position. Once the electrodes are correctly sited, a second, shorter step under general anaesthesia tunnels the connecting wires under the skin and implants the stimulator near the collarbone or in the chest. The procedure is often staged, with the stimulator placed at the same sitting or a short time later. The whole operation usually takes about 3 to 5 hours. The system is generally switched on a little later, once early swelling settles, and then programmed over several visits.

A suitable candidate is someone with a confirmed movement disorder whose symptoms still respond at least partly to medication but can no longer be controlled well enough, and who is healthy enough for surgery. Careful selection is essential: before surgery, patients undergo detailed neurological assessment, specialised imaging, a trial that confirms how far symptoms respond, and a cognitive and psychological evaluation, since the treatment is offered only to those likely to gain a clear benefit. Memory testing matters because advanced memory problems can make the treatment less suitable. Preparation also includes routine blood tests, heart checks and a medication review, with blood thinners adjusted in advance on medical advice. For international patients much of this work-up can begin remotely: recent scans, medication lists and symptom histories are reviewed before travel so that, on arrival, the assessment can be completed and surgery planned efficiently.

After surgery most patients stay in hospital for about 2 to 4 days, with the wounds healing over the following one to two weeks. The stimulation is usually not switched on straight away; once early swelling settles, the system is activated and then carefully programmed, with the settings adjusted over several visits and refined in the weeks and months that follow to find the best balance of benefit and comfort. When planning treatment abroad, it is sensible to allow roughly 1 to 2 weeks in the destination city so the wound can heal, the system can be switched on and the first programming session completed before flying. Air travel is generally safe once the team confirms the wound is healing well; staff can provide a card or note about the implanted device for security checks. Further fine-tuning of the settings can often be arranged with a specialist near home or continued remotely, and the battery is checked periodically and eventually replaced in a short procedure. International patient teams provide interpreters and coordinators throughout so language is never a barrier.

In experienced hands and a properly equipped hospital, deep brain stimulation is a well-established and relatively safe operation, and because it does not destroy brain tissue it is reversible and adjustable. As with any brain surgery it carries some risk, including a small chance of bleeding or infection, and the implanted hardware can occasionally need adjustment or, rarely, revision. Stimulation-related effects such as tingling, changes in speech, mood or balance are usually mild and can often be corrected by changing the settings, which is one of the strengths of an adjustable system. The benefit is measured by how much daily life improves: in well-selected patients, tremor, stiffness and slowness ease substantially, many reduce their medication, and independence returns. The treatment does not stop the underlying disease from progressing, but it can give years of better function and comfort. With careful patient selection, precise placement and attentive programming, most patients gain a clear and lasting improvement.